Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: Efficacy of in vivo purging by Rituximab

Bone Marrow Transplantation

Volumn 32, Issue 1, 2003, Pages 57-63

  Galimberti, S ^a   Guerrini, F ^a   Morabito, F ^b   Palumbo, G A ^c   Di Raimondo, F ^c   Papineschi, F ^a   Caracciolo, F ^a   Fazzi, R ^a   Cervetti, G ^a   Cuzzocrea, A ^b   Petrini, M ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Bone Marrow Transplant Unit   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Autologous transplantation; Follicular lymphoma; Minimal residual disease; Purging; Rituximab

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CANCER RECURRENCE; CANCER REGRESSION; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FLUORESCENCE ANALYSIS; FOLLICULAR LYMPHOMA; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LEUKAPHERESIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE;

ADULT; ANTIBODIES, MONOCLONAL; DISEASE-FREE SURVIVAL; FEMALE; GENE REARRANGEMENT; GENES, BCL-2; HUMANS; LEUKAPHERESIS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM CIRCULATING CELLS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, AUTOLOGOUS;

EID: 10744233875     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704102     Document Type: Article

References (14)

1. Gribben JG, Freedman AS, Woo SD et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of BCL2 have residual containing the BCL2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275-3280.
2. Freedman AS, Neuberg D, Mauch P et al. Long-term follow up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999; 94: 3325-3333.
3. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82: 7439-7443.
4. Corradini P, Astolfi M, Cherasco C et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724-731.
5. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336: 1290-1297.
6. Mehra S, Messner H, Minden M, Chaganti RS. Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chromosomes Cancer 2002; 33: 225-234.
7. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry 1997; 245: 154-160.
8. Decaudin D, Lepage E, Brousse N et al. Low-grade follicular lymphoma: multivariate analysis of prognostic factors in 484 patients - a study of the Groupe d'etude des lymphomes de l'adulte. J Clin Oncol 1999; 17: 2499-2505.
9. Sacchi S, Federico M, Vitolo U et al. Clinical activity and safety of combination immunotherapy with interferon-α2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. Haematologica 2001; 86: 951-958.
10. Rambaldi A, Lazzari M, Manzoni C et al. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood 2002; 99: 856-862.
11. Lazzarino M, Arcaini L, Bernasconi P et al. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma. Br J Haematol 2002; 116: 229-235.
12. Hirt C, Dolken G. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25: 419-426.
13. Magni M, Di Nicola M, Devizzi L et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. Blood 2000; 96: 864-869.
14. Moos M, Schulz R, Cremer F et al. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies. Stem Cells 1995; 13 (Suppl 3): 42-51.